These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 34638908

  • 1. Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk.
    Rabekova Z, Frankova S, Jirsa M, Neroldova M, Lunova M, Fabian O, Kveton M, Varys D, Chmelova K, Adamkova V, Hubacek JA, Spicak J, Merta D, Sperl J.
    Int J Mol Sci; 2021 Sep 29; 22(19):. PubMed ID: 34638908
    [Abstract] [Full Text] [Related]

  • 2. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
    Schneider CV, Hamesch K, Gross A, Mandorfer M, Moeller LS, Pereira V, Pons M, Kuca P, Reichert MC, Benini F, Burbaum B, Voss J, Gutberlet M, Woditsch V, Lindhauer C, Fromme M, Kümpers J, Bewersdorf L, Schaefer B, Eslam M, Bals R, Janciauskiene S, Carvão J, Neureiter D, Zhou B, Wöran K, Bantel H, Geier A, Dirrichs T, Stickel F, Teumer A, Verbeek J, Nevens F, Govaere O, Krawczyk M, Roskams T, Haybaeck J, Lurje G, Chorostowska-Wynimko J, Genesca J, Reiberger T, Lammert F, Krag A, George J, Anstee QM, Trauner M, Datz C, Gaisa NT, Denk H, Trautwein C, Aigner E, Strnad P, European Alpha-1 Liver Study Group.
    Gastroenterology; 2020 Aug 29; 159(2):534-548.e11. PubMed ID: 32376409
    [Abstract] [Full Text] [Related]

  • 3. Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease.
    Schaefer B, Mandorfer M, Viveiros A, Finkenstedt A, Ferenci P, Schneeberger S, Tilg H, Zoller H.
    Liver Transpl; 2018 Jun 29; 24(6):744-751. PubMed ID: 29573137
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S, El Feydi AE, El Kihal L, Afifi R, Benazzouz M, Hassar M, Chafik A, Pineau P, Benjelloun S.
    Arch Med Res; 2008 Feb 29; 39(2):236-41. PubMed ID: 18164971
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms of hemochromatosis, and alpha-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma.
    Gharib AF, Karam RA, Pasha HF, Radwan MI, Elsawy WH.
    Gene; 2011 Dec 10; 489(2):98-102. PubMed ID: 21925577
    [Abstract] [Full Text] [Related]

  • 6. Alpha-1-antitrypsin phenotypes in adult liver disease patients.
    Topic A, Alempijevic T, Milutinovic AS, Kovacevic N.
    Ups J Med Sci; 2009 Dec 10; 114(4):228-34. PubMed ID: 19961268
    [Abstract] [Full Text] [Related]

  • 7. alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma.
    Govindarajan S, Ashcavai M, Peters RL.
    Hepatology; 1981 Dec 10; 1(6):628-31. PubMed ID: 6171495
    [Abstract] [Full Text] [Related]

  • 8. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
    Marwick TH, Cooney PT, Kerlin P.
    Pathology; 1985 Oct 10; 17(4):649-52. PubMed ID: 3005953
    [Abstract] [Full Text] [Related]

  • 9. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P.
    J Hepatol; 2011 Apr 10; 54(4):716-22. PubMed ID: 21146242
    [Abstract] [Full Text] [Related]

  • 10. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
    Laffranchi M, Berardelli R, Ronzoni R, Lomas DA, Fra A.
    Hum Mol Genet; 2018 May 15; 27(10):1785-1793. PubMed ID: 29538751
    [Abstract] [Full Text] [Related]

  • 11. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
    Jiao X, Luo Y, Yang B, Jing L, Li Y, Liu C, Jing X, Wang F, Wang Y, Du Z, Gao Y.
    Infect Genet Evol; 2017 Apr 15; 49():66-72. PubMed ID: 28082187
    [Abstract] [Full Text] [Related]

  • 12. The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis.
    Afsharinasab M, Akbari AH, Mirzaei V, Mahmoodi M, Hajizadeh MR, Amri J, Khoshdel A.
    Horm Mol Biol Clin Investig; 2022 Dec 01; 43(4):397-403. PubMed ID: 35973212
    [Abstract] [Full Text] [Related]

  • 13. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, Fornasiere E, Bignulin S, Fumolo E, Bignulin E, Pirisi M, Toniutto P.
    Liver Int; 2011 Sep 01; 31(8):1137-43. PubMed ID: 21745286
    [Abstract] [Full Text] [Related]

  • 14. Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.
    Li Z, Li N, Zhu Q, Zhang G, Han Q, Zhang P, Xun M, Wang Y, Zeng X, Yang C, Liu Z.
    Infect Genet Evol; 2013 Mar 01; 14():240-6. PubMed ID: 23291409
    [Abstract] [Full Text] [Related]

  • 15. Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis.
    Fargion S, Klasen EC, Lalatta F, Sangalli G, Tommasini M, Fiorelli G.
    Clin Genet; 1981 Feb 01; 19(2):134-9. PubMed ID: 6258829
    [Abstract] [Full Text] [Related]

  • 16. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
    Al-Anazi MR, Matou-Nasri S, Abdo AA, Sanai FM, Khan MQ, Albenmousa A, Al-Ashgar HI, Khalaf NZ, Al-Ahdal MN, Al-Qahtani AA.
    BMC Infect Dis; 2014 Dec 31; 14():632. PubMed ID: 25551790
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM, Ahmed AI, Mosaad NA, Hassan MM, Mahmoud SH.
    Asian Pac J Cancer Prev; 2019 Nov 01; 20(11):3479-3485. PubMed ID: 31759375
    [Abstract] [Full Text] [Related]

  • 20. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.
    Cancer Epidemiol Biomarkers Prev; 2011 Jul 01; 20(7):1439-46. PubMed ID: 21610221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.